STOPAMRv1

  • Research type

    Research Study

  • Full title

    Supporting Targeting Of antibiotics in Primary care to combat antimicrobial resistance: intervention development

  • IRAS ID

    316695

  • Contact name

    Ingrid Muller

  • Contact email

    I.Muller@soton.ac.uk

  • Sponsor organisation

    University of Southampton

  • Duration of Study in the UK

    0 years, 11 months, 31 days

  • Research summary

    One in three people see doctors, nurses or pharmacists each year with common infections (colds, flu, chest, ear, sinus, skin, and urine infections). Half receive antibiotics and this has increased in COVID. Over-use of antibiotics from general practices is the leading driver of antimicrobial resistance (AMR), where antibiotics cease to be effective, meaning that most medical care could become impossible (e.g. operations, cancer care). This is one of the main threats to global health and there is an urgent need to make and implement interventions that will lower the use of antibiotics.

    Prescribers have few tools to help them lower antibiotic prescribing safely. A decision-aid we developed for sore throats reduced prescribing by 30%, improved symptom control, was safe, and was liked by doctors and nurses. This aid has now been extended and will be merged into a larger evidence-based digital toolkit designed to provide: support for prescribing strategies for all common infections in adults and children; information for discussion with patients to help them understand the prescribing strategy.

    This research is funded by NIHR and will develop the toolkit and carry out interviews with prescribers and pharmacists recruited by email and online to optimise the content so that the toolkit is easy to use and helpful. We will also interview members of the public recruited through social media and community platforms to optimise the contents of the patient information to ensure that it is understandable and engaging.

  • REC name

    North East - Newcastle & North Tyneside 1 Research Ethics Committee

  • REC reference

    22/NE/0122

  • Date of REC Opinion

    21 Jul 2022

  • REC opinion

    Further Information Favourable Opinion